Extended thrombotic prophylaxis in COVID-19 early discharge: A retrospective cohort study.

ABSTRACT:

Introduction/background

Due to limits in available staff and space during the COVID-19 pandemic, home monitoring programmes were introduced, reducing strain on resources, and preventing readmissions. Several hospitals included prophylaxis for venous thrombotic events (VTE), as COVID-19 appeared to be thrombogenic. Other hospitals did not, expecting patients to be more mobile while at home. Our aim was to determine whether the administration of nadroparin has led to a difference in VTE occurrence between two groups of previously included patients.

Materials and methods

Retrospective cohort study of two cohorts included in home monitoring with the same protocol, except for nadroparin prophylaxis.

Results

663 patients were analysed in equal groups from two hospitals. No

SUBMITTER: Van't Hoff ST 

PROVIDER: S-EPMC12857994 | biostudies-literature | 2026

REPOSITORIES: biostudies-literature